FindTrial
Sign In

Clinical Efficacy of Kameshwar Modaka in Premature Ejaculation

To Study the clinical efficacy of Kameshwar Modak in Premature ejaculation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038995
Enrollment
30
Registered
2021-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F524- Premature ejaculation

Interventions

None listed

Sponsors

Hempstreet Medicare Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male Patients- Stable, Monogamous, hetero sexual 2. Non-alcoholic or should avoid alcohol during this period of 2 months. 3. No Hypertension/cardiac problems 4. In good general health. 5. Partner must have negative urine pregnancy test

Exclusion criteria

Exclusion criteria: Patients having 1. Hypertension 2. Cardiac problem 3. Heavily Alcoholic 4. Not taking any medicines for sedation or depression etc. 5. Those patients who show any toxicity symptoms during trial period.

Design outcomes

Primary

MeasureTime frame
Improvement in the IVELT (Intravaginal ejaculatory latency time) as assessed by Partner and Self assessment questionnaireTimepoint: 0, 15, 30, 45 days—

Secondary

MeasureTime frame
Safety and tolerability of the formulation as assessed by adverse drug reactions.Timepoint: 0, 15, 30, 45 days—

Countries

India

Contacts

Public ContactDr Sanjay Erande

Dr Erandes Vedsuman Men and Womens Clinic

vedsumanclinic@gmail.com8668999034

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026